Burn & Trauma Research Center (BTRC),Noida

Details Associates
Medical Suppliers In Uttar Pradesh

Name :

Burn & Trauma Research Center (BTRC),Noida

Address  :

Vinayak Hospital, 5th floor
NH-1, Sector 27, Atta

Town  :

Noida

State  :

Uttar Pradesh

Country  :

INDIA

Post Code:

201 301

Phone  :

91 120 2541337 39, 91 88261 37605

Fax  :

91 120 2544801

Web URL  :

Available
Specialization
  • Cosmetic Surgery
  • Plastic Surgery
Facilities

Total Number Of Beds : 22

Advance Facility

  • Blood Bank
Description
BTRC Noida is a branch of Dr Tiwarys already running Burn amp Plastic Surgery Hospital Apollo Burn Hospital at Patna

Located on the 5th Floor of the Vinayak Hospital in the heart of Noida and backed by the necessary skill infrastructure amp expertise BTRC presents you with the best possible chance of a speedy recovery from Burn amp Post Burn Complications of variable nature amp intensity

Our Burn amp Trauma Research Center at Vinayak Hospital Noida is one of the nations most advanced burn centers It has a dedicated fulltime medical staff that uses the most advanced burncare technologies and reconstructive surgical techniques The BTRC facility at Vinayak Hospital Noida provides the latest in patient intensive care safety privacy and comfort Patient rooms are mostly private and feature stateoftheart infection control

Our Post Burn Contractures Deformities amp Scar Management Program offers the latest techniques to limit cosmetic and functional disabilities Our Outpatient Burn Center offers OPD followup outpatient care for patients after their hospitalization and for people whose burns are less severe Throughout the care process patients receive the required support they need from our Dieticians Physiotherapists Psychologists and Psychiatrists

NEWS
Cancer Drugs Get Cheaper in India

Roche Holding AG is cutting the price of two expensive cancer drugs in India and giving them new names in an effort to gain market share and avoid competition from generic drugs in the fastgrowing economy The move marks a shift for the Swiss drug maker which long has argued that consumers everywhere should pay the same price for its medications By... Read More

ARTICLES
Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More